Beam Therapeutics Inc.
BEAM | NASDAQ
$25.26
+$0.31 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$25.43
+$0.16 (+0.65%)
Pre-market:
Sep 22, 2026, 8:47 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -34.22 | -5.41 | -15.83 | -9.47 | -13.81 | -14.87 |
PEG Ratio | 0.42 | -0.03 | 0.27 | 0.33 | -2.71 | -0.06 |
PS Ratio | 19.62 | 32.14 | 5.56 | 44.95 | 98.73 | 158.97K |
PB Ratio | 2.21 | 2.78 | 2.14 | 3.73 | 6.19 | 15.54 |
P/FCF Ratio | -7.61 | -5.73 | -11.48 | -103.63 | -45.26 | -34.04 |
P/OCF Ratio | -7.94 | -5.88 | -14.08 | 121.56 | -77.24 | -39.85 |
OCF/S Ratio | -246.95 | -546.69 | -39.50 | 36.98 | -127.82 | -398.92K |
Debt / Equity Ratio | 0.24 | 0.22 | 0.18 | 0.24 | 0.18 | 0.44 |
Quick Ratio | 13.09 | 4.82 | 5.89 | 4.89 | 5.96 | 3.01 |
Current Ratio | 13.09 | 4.82 | 5.89 | 4.89 | 5.96 | 3.01 |
Asset Turnover | 0.09 | 0.06 | 0.26 | 0.05 | 0.04 | 0 |
Interest Coverage | -8.77 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -6.46% | -51.36% | -13.50% | -39.41% | -44.83% | -79.24% |
Return on Assets | -5.40% | -34.13% | -9.08% | -21.55% | -25.14% | -43.08% |
Return on Invested Capital | -27.43% | -44.44% | -13.93% | -29.99% | -30.88% | -37.33% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 84.05% | -478.67% | 100% | -411.48% | -347.75% | -429.81K% |
Net Profit Margin | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% | -810.8K% |
Pretax Profit Margin | -57.24% | -593.07% | -34.73% | -468.94% | -714.91% | -810.8K% |
Operating Profit Margin | -274.57% | -654.25% | -46.73% | -555.61% | -757.01% | -553.17K% |
FCF Margin | -257.65% | -560.77% | -48.43% | -43.37% | -218.11% | -467.08K% |
EBITDA Margin | -21.41% | -558.55% | -26.91% | -445.72% | -443.76% | -533.44K% |
Add to Watchlist
Select watchlists to add or remove BEAM